Back to top
more

Genetic Technologies (GENE)

(Delayed Data from NSDQ)

$2.39 USD

2.39
18,129

+0.01 (0.42%)

Updated Apr 23, 2024 03:58 PM ET

After-Market: $2.40 +0.01 (0.42%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (78 out of 252)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Fiscal Year End for Genetic Technologies Ltd falls in the month of June.

All items in Millions except Per Share data.

6/30/2023 6/30/2022 6/30/2021 6/30/2020 6/30/2019
Assets          
Cash & Equivalents 5 9 16 10 2
Receivables 1 2 1 1 1
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 0 0 0 0 0
Total Current Assets 7 11 17 10 2
Net Property & Equipment 0 0 0 0 0
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 2 4 0 0 0
Deposits & Other Assets 0 0 0 0 0
Total Assets 10 15 17 11 2
Liabilities & Shareholders Equity 6/30/2023 6/30/2022 6/30/2021 6/30/2020 6/30/2019
Notes Payable 0 0 0 0 0
Accounts Payable 1 2 1 0 1
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 1 1 0 0 0
Total Current Liabilities 2 3 1 1 1
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 1 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 2 3 1 2 1
Shareholders Equity 6/30/2023 6/30/2022 6/30/2021 6/30/2020 6/30/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 113 0 0 0
Capital Surplus 0 0 0 0 0
Retained Earnings -106 -109 -107 -91 -93
Other Equity 113 8 123 100 94
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 8 12 16 9 1
Total Liabilities & Shareholder's Equity 10 15 17 11 2
Total Common Equity 8 12 16 9 1
Shares Outstanding 3.80 3.00 3.00 2.70 0.90
Book Value Per Share 1.98 3.97 5.36 3.24 1.41

Fiscal Year End for Genetic Technologies Ltd falls in the month of June.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 -99,997 -99,999 5 -99,999
Receivables NA 1 NA 1 NA
Notes Receivable NA NA NA 0 NA
Inventories NA 0 NA 0 NA
Other Current Assets NA 0 NA 0 NA
Total Current Assets NA 4 NA 7 NA
Net Property & Equipment NA 0 NA 0 NA
Investments & Advances NA NA NA 0 NA
Other Non-Current Assets NA NA NA 0 NA
Deferred Charges NA 0 NA 0 NA
Intangibles NA 1 NA 2 NA
Deposits & Other Assets NA 0 NA 0 NA
Total Assets NA 6 NA 10 NA
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA NA NA 0 NA
Accounts Payable NA 1 NA 1 NA
Current Portion Long-Term Debt NA NA NA 0 NA
Current Portion Capital Leases NA 0 NA 0 NA
Accrued Expenses NA NA NA 0 NA
Income Taxes Payable NA NA NA 0 NA
Other Current Liabilities NA 1 NA 1 NA
Total Current Liabilities NA 2 NA 2 NA
Mortgages NA NA NA 0 NA
Deferred Taxes/Income NA 0 NA 0 NA
Convertible Debt NA NA NA 0 NA
Long-Term Debt NA NA NA 0 NA
Non-Current Capital Leases NA 0 NA 0 NA
Other Non-Current Liabilities NA NA 0 NA
Minority Interest (Liabilities) NA NA NA 0 NA
Total Liabilities NA 2 NA 2 NA
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA NA NA 0 NA
Common Stock (Par) NA 105 NA 0 NA
Capital Surplus NA NA NA 0 NA
Retained Earnings NA -105 NA -106 NA
Other Equity NA 3 NA 113 NA
Treasury Stock NA NA NA 0 NA
Total Shareholder's Equity NA 3 NA 8 NA
Total Liabilities & Shareholder's Equity NA 6 NA 10 NA
Total Common Equity 0 100,002 0 8 0
Shares Outstanding 3.80 3.80 3.80 3.80 3.80
Book Value Per Share 0.00 26,316.35 0.00 1.98 0.00